2016_BT PROSTATE CANCER COURSE BOOK

1999 AMERICAN BRACHYTHERAPY SOCIETY (ABS) RECOMMENDATIONS FOR TRANSPERINEAL PERMANENT BRACHYTHERAPY OF PROSTATE CANCER

• Clinical Exclusion Criteria: • Life expectancy < 5 years • Large or poorly healed TURP defect • Unacceptable operative risks • Distant metastases